Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

PaperCitations, authors & open-access status

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 297 citations, 2012 year and closed oa status.

297
Citations
2012
Year
closed
OA Status

Related on ScholarIQ

Yi‐Ming Chen
Author
The Lancet Oncology
Journal
Lymphoma Diagnosis and Treatment
Topic
Lymphoma Diagnosis and Treatment
Topic
Multiple Myeloma Research and Treatments
Topic
Cutaneous lymphoproliferative disorders research
Topic
470M+ articles · free account